Claude Vaney

Papers

Total Citations

102

H-Index

About

Claude Vaney is a leading figure in neurorehabilitation, best known for his rigorous, evidence-based approach to evaluating assistive technologies for patients with multiple sclerosis (MS). His primary research focuses on gait rehabilitation, comparative effectiveness of robotic therapy, and patient-centered outcomes in chronic neurological conditions. Vaney’s most impactful work, a 2011 randomized controlled trial cited over 100 times, directly challenged prevailing assumptions by demonstrating that robotic-assisted step training (Lokomat) was not superior to equal-intensity over-ground rehabilitation for improving walking capacity or quality of life in MS patients. This landmark study provided critical, sobering evidence that high-tech interventions do not automatically outperform well-designed conventional therapy, shaping clinical guidelines and prompting a more nuanced integration of robotics into rehabilitation. Through this and related work, Vaney has emphasized the importance of rigorous trial design and functional outcomes over technological novelty. His contributions have helped reframe the conversation around neurorehabilitation, advocating for evidence-based practice and patient-specific treatment intensity over the allure of new devices.